Home › Funds › Two Sigma Investments › VYGR
Two Sigma Investments position in VYGR
VOYAGER THERAPEUTICS INC · Health Care
Latest position (Q2 2026)948.52K sh
Reported value held$3.32M
Portfolio Weight0.00%
First reportedQ1 2022
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2022 | 96.46K | $735.00K | New |
| Q2 2022 | 33.43K | $198.00K | Reduce |
| Q1 2023 | 26.00K | $200.46K | New |
| Q2 2023 | 57.40K | $657.17K | Add |
| Q3 2023 | 33.60K | $260.40K | Reduce |
| Q4 2023 | 22.10K | $186.52K | Reduce |
| Q1 2024 | 22.11K | $205.86K | Hold |
| Q3 2025 | 140.72K | $657.14K | New |
| Q4 2025 | 222.71K | $875.26K | Add |
| Q1 2026 | 615.66K | $2.38M | Add |
| Q2 2026 | 948.52K | $3.32M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding VYGR
- BlackRock Inc 5.17M sh · $18.10M · Q2 2026
- Millennium Management 4.44M sh · $15.55M · Q2 2026
- Vanguard Group 3.27M sh · $12.84M · Q4 2025
- Geode Capital Management 1.33M sh · $4.66M · Q2 2026
- Morgan Stanley 697.33K sh · $2.44M · Q2 2026
- Renaissance Technologies 495.24K sh · $1.73M · Q2 2026
- Northern Trust Corp 411.80K sh · $1.44M · Q2 2026
- AQR Capital Management 356.11K sh · $1.25M · Q2 2026
- Goldman Sachs Group 338.48K sh · $1.18M · Q2 2026
- JPMorgan Chase & Co 276.21K sh · $988.84K · Q2 2026
- Point72 Asset Management 236.08K sh · $826.29K · Q2 2026